Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 6/2021

01-12-2021 | Computed Tomography | Case Report

Solitary port-site metastasis 42 months after laparoscopic distal gastrectomy for gastric cancer

Authors: Tsutomu Namikawa, Akira Marui, Keiichiro Yokota, Ian Fukudome, Masaya Munekage, Sunao Uemura, Hiromichi Maeda, Hiroyuki Kitagawa, Michiya Kobayashi, Kazuhiro Hanazaki

Published in: Clinical Journal of Gastroenterology | Issue 6/2021

Login to get access

Abstract

We report a case of solitary port-site recurrence after laparoscopy-assisted distal gastrectomy for advanced gastric cancer. A 66-year-old man had previously undergone laparoscopy-assisted gastrectomy with regional lymph-node dissection for advanced gastric cancer, which was a poorly differentiated adenocarcinoma invading the subserosal layer with lymphatic infiltration and no lymph-node metastases. He experienced dull pain in the left upper quadrant of the abdomen 42 months after the surgery. On physical examination, erythematous induration of the skin around the scar of the port insertion was observed in the left upper quadrant of the abdomen. Abdominal ultrasonography and contrast-enhanced computed tomography revealed a subcutaneous lesion with a well-defined mass measuring 3.0 cm in diameter located in the left upper quadrant of the abdomen. A skin biopsy revealed a metastatic adenocarcinoma from gastric cancer. Since there was no evidence of further metastatic lesions in other organs, the patient underwent surgical resection of the metastatic tumor arising at the port site. The abdominal wall tumor was resected with a leaf-skin incision and an adequate safety margin, and the inferior border of the tumor reached the muscular layer, which was resected with the tumor. Pathological examination confirmed the diagnosis of a poorly differentiated adenocarcinoma in the subcutaneous tissue with invasion of the muscle layer at the port site. The postoperative course was uneventful; chemotherapy using oxaliplatin plus S-1 was administered, and the patient was in good health with no evidence of the disease for 3 months postoperatively. Although port-site metastasis after laparoscopic gastrectomy for gastric cancer is a rare recurrence form, we should be aware of this issue, and further studies and assessments of additional cases are needed to establish a treatment strategy.
Literature
1.
go back to reference Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33.PubMed Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33.PubMed
2.
go back to reference Katai H, Mizusawa J, Katayama H, et al. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol. 2020;5:142–51.CrossRefPubMed Katai H, Mizusawa J, Katayama H, et al. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol. 2020;5:142–51.CrossRefPubMed
3.
go back to reference Inaki N, Etoh T, Ohyama T, et al. A multi-institutional, prospective, Phase II feasibility study of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for locally advanced gastric cancer (JLSSG0901). World J Surg. 2015;39:2734–41.CrossRefPubMed Inaki N, Etoh T, Ohyama T, et al. A multi-institutional, prospective, Phase II feasibility study of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for locally advanced gastric cancer (JLSSG0901). World J Surg. 2015;39:2734–41.CrossRefPubMed
4.
go back to reference Kodera Y, Yoshida K, Kumamaru H, et al. Introducing laparoscopic total gastrectomy for gastric cancer in general practice: a retrospective cohort study based on a nationwide registry database in Japan. Gastric Cancer. 2019;22:202–13.CrossRefPubMed Kodera Y, Yoshida K, Kumamaru H, et al. Introducing laparoscopic total gastrectomy for gastric cancer in general practice: a retrospective cohort study based on a nationwide registry database in Japan. Gastric Cancer. 2019;22:202–13.CrossRefPubMed
5.
go back to reference Emoto S, Ishigami H, Yamaguchi H, et al. Port-site metastasis after laparoscopic surgery for gastrointestinal cancer. Surg Today. 2017;47:280–3.CrossRefPubMed Emoto S, Ishigami H, Yamaguchi H, et al. Port-site metastasis after laparoscopic surgery for gastrointestinal cancer. Surg Today. 2017;47:280–3.CrossRefPubMed
6.
go back to reference Yamaguchi K, Hirabayashi Y, Shiromizu A, et al. Enhancement of port site metastasis by hyaluronic acid under CO2 pneumoperitoneum in a murine model. Surg Endosc. 2001;15:504–7.CrossRefPubMed Yamaguchi K, Hirabayashi Y, Shiromizu A, et al. Enhancement of port site metastasis by hyaluronic acid under CO2 pneumoperitoneum in a murine model. Surg Endosc. 2001;15:504–7.CrossRefPubMed
7.
go back to reference Hirabayashi Y, Yamaguchi K, Shiraishi N, et al. Development of port-site metastasis after pneumoperitoneum. Surg Endosc. 2002;16:864–8.CrossRefPubMed Hirabayashi Y, Yamaguchi K, Shiraishi N, et al. Development of port-site metastasis after pneumoperitoneum. Surg Endosc. 2002;16:864–8.CrossRefPubMed
8.
go back to reference Hirabayashi Y, Yamaguchi K, Shiraishi N, et al. Port-site metastasis after CO2 pneumoperitoneum: role of adhesion molecules and prevention with antiadhesion molecules. Surg Endosc. 2004;18:1113–7.CrossRefPubMed Hirabayashi Y, Yamaguchi K, Shiraishi N, et al. Port-site metastasis after CO2 pneumoperitoneum: role of adhesion molecules and prevention with antiadhesion molecules. Surg Endosc. 2004;18:1113–7.CrossRefPubMed
9.
go back to reference Kashihara H, Shimada M, Yoshikawa K, et al. Risk factors for recurrence of gastric cancer after curative laparoscopic gastrectomy. J Med Invest. 2017;64(1):79–84.CrossRefPubMed Kashihara H, Shimada M, Yoshikawa K, et al. Risk factors for recurrence of gastric cancer after curative laparoscopic gastrectomy. J Med Invest. 2017;64(1):79–84.CrossRefPubMed
10.
go back to reference Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.
11.
go back to reference Lee YJ, Ha WS, Park ST, et al. Port-site recurrence after laparoscopy-assisted gastrectomy: report of the first case. J Laparoendosc Adv Surg Tech A. 2007;17:455–7.CrossRefPubMed Lee YJ, Ha WS, Park ST, et al. Port-site recurrence after laparoscopy-assisted gastrectomy: report of the first case. J Laparoendosc Adv Surg Tech A. 2007;17:455–7.CrossRefPubMed
13.
go back to reference Kim SH, Kim DJ, Kim W. Long-term survival following port-site metastasectomy in a patient with laparoscopic gastrectomy for gastric cancer: A case report. J Gastric Cancer. 2015;15:209–13.CrossRefPubMedPubMedCentral Kim SH, Kim DJ, Kim W. Long-term survival following port-site metastasectomy in a patient with laparoscopic gastrectomy for gastric cancer: A case report. J Gastric Cancer. 2015;15:209–13.CrossRefPubMedPubMedCentral
14.
go back to reference Fukui Y, Kubo N, Sakurai K, et al. Metachronous port site, muscular and subcutaneous metastases from a gastric adenocarcinoma: a case report and review of articles. Surg Case Rep. 2021;7:124.CrossRefPubMedPubMedCentral Fukui Y, Kubo N, Sakurai K, et al. Metachronous port site, muscular and subcutaneous metastases from a gastric adenocarcinoma: a case report and review of articles. Surg Case Rep. 2021;7:124.CrossRefPubMedPubMedCentral
15.
go back to reference Emoto S, Ishigami H, Hidemura A, et al. Complications and management of an implanted intraperitoneal access port system for intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. Jpn J Clin Oncol. 2012;42:1013–9.CrossRefPubMed Emoto S, Ishigami H, Hidemura A, et al. Complications and management of an implanted intraperitoneal access port system for intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. Jpn J Clin Oncol. 2012;42:1013–9.CrossRefPubMed
16.
go back to reference Chue KM, Chan DYS, So JBY. Cutaneous port-site recurrence secondary to tumour seeding following implantation of an intraperitoneal chemotherapy access port for gastric cancer. Pleura Peritoneum. 2020;5:20200102.CrossRefPubMedPubMedCentral Chue KM, Chan DYS, So JBY. Cutaneous port-site recurrence secondary to tumour seeding following implantation of an intraperitoneal chemotherapy access port for gastric cancer. Pleura Peritoneum. 2020;5:20200102.CrossRefPubMedPubMedCentral
17.
go back to reference Deogracias ML, Rodríguez-Sanjuán JC, de la Torre F, et al. Absence of port-site metastases following staging laparoscopy for gastric carcinoma. Rev Esp Enferm Dig. 2006;98:755–9.CrossRefPubMed Deogracias ML, Rodríguez-Sanjuán JC, de la Torre F, et al. Absence of port-site metastases following staging laparoscopy for gastric carcinoma. Rev Esp Enferm Dig. 2006;98:755–9.CrossRefPubMed
18.
go back to reference Kwong MLM, Sampah MES, Bello BL, et al. Port site metastases after minimally invasive resection for colorectal cancer: A retrospective study of 13 patients. Surg Oncol. 2019;29:20–4.CrossRefPubMed Kwong MLM, Sampah MES, Bello BL, et al. Port site metastases after minimally invasive resection for colorectal cancer: A retrospective study of 13 patients. Surg Oncol. 2019;29:20–4.CrossRefPubMed
20.
go back to reference Balli JE, Franklin ME, Almeida JA, et al. How to prevent port-site metastases in laparoscopic colorectal surgery. Surg Endosc. 2000;14:1034–6.CrossRefPubMed Balli JE, Franklin ME, Almeida JA, et al. How to prevent port-site metastases in laparoscopic colorectal surgery. Surg Endosc. 2000;14:1034–6.CrossRefPubMed
21.
go back to reference Furukawa M, Izumi S, Asano H, et al. Late umbilical port-site recurrence of a gastrointestinal stromal tumor with an acquired PDGFRalpha mutation after laparoscopic resection: report of a case. Surg Laparosc Endosc Percutan Tech. 2012;22:e109–11.CrossRefPubMed Furukawa M, Izumi S, Asano H, et al. Late umbilical port-site recurrence of a gastrointestinal stromal tumor with an acquired PDGFRalpha mutation after laparoscopic resection: report of a case. Surg Laparosc Endosc Percutan Tech. 2012;22:e109–11.CrossRefPubMed
Metadata
Title
Solitary port-site metastasis 42 months after laparoscopic distal gastrectomy for gastric cancer
Authors
Tsutomu Namikawa
Akira Marui
Keiichiro Yokota
Ian Fukudome
Masaya Munekage
Sunao Uemura
Hiromichi Maeda
Hiroyuki Kitagawa
Michiya Kobayashi
Kazuhiro Hanazaki
Publication date
01-12-2021
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 6/2021
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-021-01519-y

Other articles of this Issue 6/2021

Clinical Journal of Gastroenterology 6/2021 Go to the issue